Predictive, preventive, and personalized medicine in statin-treated patients with NSTE-ACS, HFpEF, and type 2 diabetes: a data-driven model for long-term residual risk assessment
This 3PM/PPPM-guided framework enables early identification of high-risk phenotypes among NSTE-ACS patients with HFpEF and type 2 diabetes before irreversible clinical deterioration occurs.